Aclarion (ACON) EBITDA Margin (2021 - 2026)
Aclarion (ACON) reported EBITDA Margin of 14129.33% for Q1 2026, down 627337.0% on a YoY basis from N/an in Q1 2025, and down 31.01% quarter-over-quarter from 10785.18% in Q4 2025.
Aclarion (ACON) EBITDA Margin (2021 - 2026) Analysis & Trends
Aclarion has reported EBITDA Margin for 6 years, with the latest figure at 14129.33% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin fell 627337.0% year-over-year to 14129.33%; the trailing twelve-month figure through Mar 2026 stood at 10975.1% (down 1326194.0% YoY), and the FY2025 full-year result was 9312.55%, down 1251711.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 14129.33%, down from 10785.18% in the prior quarter.
- The five-year high for EBITDA Margin was 50548.11% in Q4 2024, with the low at 20726.38% in Q2 2022.
- Historically, EBITDA Margin has averaged 6023.9% across 5 years, with a median of 8963.12% in 2022.
- Annual changes were most pronounced in 2024 — EBITDA Margin surged 5871178 bps — and 2025, when it plunged 6133330 bps.
- Aclarion's EBITDA Margin stood at 4184.99% in 2022, then tumbled by 95 bps to 8163.67% in 2023, then jumped by 719 bps to 50548.11% in 2024, then slumped by 121 bps to 10785.18% in 2025, then plunged by 31 bps to 14129.33% in 2026.
- The last three EBITDA Margin figures came in at 14129.33% (Q1 2026), 10785.18% (Q4 2025), and 9666.16% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 26.39% |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 3.36% |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 29.03% |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 19.09% |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -11.30% |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 17.08% |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 27.87% |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 1.25% |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 5.44% |
| 10 | Aclarion | 6.68 Mn | -12.07 Mn | 3,750.00 | -14,129.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14,129.33% |
| Dec 31, 2025 | -10,785.18% |
| Sep 30, 2025 | -9,666.16% |
| Jun 30, 2025 | -8,988.60% |
| Mar 31, 2025 | -7,855.96% |
| Dec 31, 2024 | 50,548.11% |
| Sep 30, 2024 | -8,995.34% |
| Jun 30, 2024 | -10,350.57% |
| Mar 31, 2024 | -12,609.32% |
| Dec 31, 2023 | -8,163.67% |
| Sep 30, 2023 | -6,095.86% |
| Jun 30, 2023 | -8,236.88% |
| Mar 31, 2023 | -4,637.86% |
| Dec 31, 2022 | -4,184.99% |
| Sep 30, 2022 | -8,963.12% |
| Jun 30, 2022 | -20,726.38% |
| Mar 31, 2022 | -8,565.26% |
| Dec 31, 2021 | -8,922.25% |
| Sep 30, 2021 | -7,337.83% |
| Jun 30, 2021 | -2,445.84% |